Australian CCC re-authorizes code

7 May 2006

The Australian Competition and Consumer Commission is proposing to authorize for three years a new edition of the code governing pharmaceutical companies' dealings with doctors.

"The code governs the activities of pharmaceutical companies when they promote prescription medicines to doctors," said ACCC Chairman, Graeme Samuel, adding: "it has been developed by Medicines Australia, the national association representing the industry."

The code regulates advertising of prescription drugs to the medical profession. Advertising to consumers of prescription medicines is prohibited by the Therapeutic Goods Administration. It also regulates matters such as drug company sponsorship of medical conferences; the payment of travel and accommodation expenses of doctors attending such meetings; and the provision of other forms of hospitality.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight